27-hydroxycholesterol has been researched along with docetaxel anhydrous in 1 studies
| Studies (27-hydroxycholesterol) | Trials (27-hydroxycholesterol) | Recent Studies (post-2010) (27-hydroxycholesterol) | Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) |
|---|---|---|---|---|---|
| 345 | 11 | 214 | 12,110 | 3,216 | 6,920 |
| Protein | Taxonomy | 27-hydroxycholesterol (IC50) | docetaxel anhydrous (IC50) |
|---|---|---|---|
| Kinesin-like protein KIF11 | Homo sapiens (human) | 0.0014 | |
| Nucleotide-binding oligomerization domain-containing protein 2 | Homo sapiens (human) | 5.0119 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghribi, O; Guo, B; Hammer, KD; Meyer, M; Raza, S; Schommer, J | 1 |
1 other study(ies) available for 27-hydroxycholesterol and docetaxel anhydrous
| Article | Year |
|---|---|
27-Hydroxycholesterol stimulates cell proliferation and resistance to docetaxel-induced apoptosis in prostate epithelial cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cells, Cultured; Docetaxel; Drug Resistance, Neoplasm; Epithelial Cells; Humans; Hydroxycholesterols; Kallikreins; Male; Promoter Regions, Genetic; Prostate; Prostate-Specific Antigen; Receptors, Androgen; Taxoids | 2016 |